Stability of dilutions of the recombinant factor VIII Kogenate FS determined by one-stage and chromogenic assays using plasma-derived and concentrate standards.

被引：0
|
作者：
Rand, ML
Schmugge, M
Clark, D
Lillicrap, D
Blanchette, VS
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Queens Univ, Kingston, ON K7L 3N6, Canada
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2801
引用
收藏
页码：711A / 711A
页数：1
相关论文
共 18 条
  • [1] Single dose pharmacokinetic evaluation of ReFacto, the B domain-deleted recombinant factor VIII (BDDrFVIII), using one-stage and chromogenic assays: Comparison between plasma and concentrate laboratory standards.
    Morfini, M
    Cinotti, S
    Paladino, E
    Mannucci, PM
    Bellatreccia, A
    Bianchi, C
    BLOOD, 2000, 96 (11) : 490A - 490A
  • [2] Recombinant to modified factor VIII and factor IX - chromogenic and one-stage assays issues
    Kitchen, S.
    Kershaw, G.
    Tiefenbacher, S.
    HAEMOPHILIA, 2016, 22 : 72 - 77
  • [3] Comparison of potencies in plasma derived Factor VIII concentrates using the one-stage, two-stage and chromogenic assays.
    Schwartz, BA
    Elliott, G
    Kleszynski, R
    BLOOD, 2002, 100 (11) : 698A - 699A
  • [4] Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay
    Lee, CA
    Owens, D
    Bray, G
    Giangrande, P
    Collins, P
    Hay, C
    Gomperts, E
    Schroth, P
    Barrowcliffe, T
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1644 - 1647
  • [5] Determination of clotting factor VIII activity in mammals using one-stage clotting and chromogenic assays
    Lutze, G
    Lutze, G
    Kutschmann, K
    Schröpel, M
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2002, 115 (7-8): : 297 - 302
  • [6] In vivo pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay.
    Lee, C
    Owens, D
    Lilley, P
    Giangrande, P
    Collins, P
    Hay, C
    Bray, G
    Gomperts, E
    Schroth, P
    Barrowscliffe, T
    BLOOD, 1997, 90 (10) : 143 - 143
  • [7] One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin
    Lippi, Giuseppe
    Franchini, Massimo
    Favaloro, Emmanuel. J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (01) : 1 - 3
  • [8] The effect of different APTT reagents on the potencies of plasma-derived and recombinant factor IX concentrates in one-stage clotting assays
    Wilmot, H., V
    Hogwood, J.
    Gray, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 829 - 829
  • [9] Differences in the activation of recombinant factor VIII may be the cause of the discrepancy between the one-stage and the chromogenic potency assays.
    Regan, LM
    Altenhoff, RL
    Helgeson, EA
    BLOOD, 1998, 92 (10) : 98B - 98B
  • [10] Pharmacokinetics of reformulated B-domain deleted recombinant factor VIII (BDD-rFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS)
    Santoro, C.
    Ferrante, F.
    Iorio, A.
    Biondo, F.
    Pignoloni, P.
    Mazzucconi, M.
    HAEMOPHILIA, 2008, 14 : 10 - 10
12